GTX (gemcitabine/taxotere/xeloda)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GTX (gemcitabine/taxotere/xeloda), covering 2020-09-14 to 2020-09-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer [Phase 1, Phase 2]